Skip to main content
Top
Published in: Clinical Rheumatology 4/2007

01-04-2007 | Original Article

Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study

Authors: Aşkin Ateş, Gülay Kinikli, Murat Turgay, Gülay Akay, Güner Tokgöz

Published in: Clinical Rheumatology | Issue 4/2007

Login to get access

Abstract

The value of rheumatoid factor (RF) isotypes for assessing rheumatoid arthritis (RA) remains debatable. In this study, we have examined the relationships between RF isotypes and disease activity and severity in RA patients. Sixty-two patients with RA, 48 women and 14 men, were studied. RF was measured by nephelometry (RF–N) and IgG–, IgA–, and IgM–RF isotypes were measured using enzyme-linked immunosorbent assay. Serum C-reactive protein and erythrocyte sedimentation rate were also determined. The patients were classified according to disease activity, joint damage, functional status, and presence of pulmonary involvement, rheumatoid nodule, and secondary Sjögren’s syndrome. Although the patients with active disease had significantly higher IgA–RF and IgM–RF levels compared to inactive patients, IgA–RF and IgM–RF were not found to be independently associated with disease activity in multivariate analysis. In patients with severe joint damage, IgA–RF and RF–N were significantly higher than those of the other patients. Multiple regression analysis showed that IgA–RF was the unique variable independently associated to severe joint damage. The patients with class III and IV functional index had significantly higher IgM–RF, IgA–RF, and RF–N levels compared to the patients with class I and II functional index; however, RFs were not significantly associated with functional status in multivariate analysis. IgA–RF and IgM–RF were significantly associated with pulmonary involvement and rheumatoid nodule, respectively. No significant associations were found between RF isotypes and secondary Sjögren’s syndrome. Our results suggest that the clinical usefulness of IgA and IgM isotypes is better than RF–N. Elevated IgA–RF may be a marker of erosive disease. The usefulness of RF isotypes for monitoring disease activity or functional status appears to be limited.
Literature
1.
go back to reference Bartfeld H (1969) Distribution of rheumatoid factor activity in nonrheumatoid states. Ann NY Acad Sci 168:30–40PubMedCrossRef Bartfeld H (1969) Distribution of rheumatoid factor activity in nonrheumatoid states. Ann NY Acad Sci 168:30–40PubMedCrossRef
2.
go back to reference Silvestris F, Anderson W, Goodwin JS, Williams RC Jr (1985) Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 35:234–244PubMedCrossRef Silvestris F, Anderson W, Goodwin JS, Williams RC Jr (1985) Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 35:234–244PubMedCrossRef
3.
go back to reference Van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiologic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525PubMedCrossRef Van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van’t Hof MA, van Rijswijk MH, van de Putte LBA (1992) Prognostic factors for radiologic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525PubMedCrossRef
4.
go back to reference Möttenen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P (1998) Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with ‘sawtooth’ strategy. Ann Rheum Dis 57:533–539CrossRef Möttenen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P (1998) Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with ‘sawtooth’ strategy. Ann Rheum Dis 57:533–539CrossRef
5.
go back to reference Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 42:939–946PubMedCrossRef Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X (2003) Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 42:939–946PubMedCrossRef
6.
go back to reference Tarkowski A, Nilsson LA (1983) Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 12:129–135PubMed Tarkowski A, Nilsson LA (1983) Isotype-specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J Clin Lab Immunol 12:129–135PubMed
7.
go back to reference Möttönen T, Hannonen P, Jokinen I, Arvilommi M, Oka M (1988) Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritis. Scand J Rheumatol 75(Suppl):244–249 Möttönen T, Hannonen P, Jokinen I, Arvilommi M, Oka M (1988) Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritis. Scand J Rheumatol 75(Suppl):244–249
8.
go back to reference Jonsson T, Thorsteinsson J, Kolbeinsson A, Jonasdottir E, Sigfusson N, Valdimarsson H (1992) Population study of the importance of rheumatoid factor isotypes in adult. Ann Rheum Dis 51:863–868PubMed Jonsson T, Thorsteinsson J, Kolbeinsson A, Jonasdottir E, Sigfusson N, Valdimarsson H (1992) Population study of the importance of rheumatoid factor isotypes in adult. Ann Rheum Dis 51:863–868PubMed
9.
go back to reference van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029–1035PubMed van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029–1035PubMed
10.
go back to reference van Leeuwen MA, Westra J, van Riel PLCM, Limburg PC, van Rijswijk MH (1995) IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 24:146–153PubMed van Leeuwen MA, Westra J, van Riel PLCM, Limburg PC, van Rijswijk MH (1995) IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression? Scand J Rheumatol 24:146–153PubMed
11.
go back to reference Houssien DA, Jonsson T, Davies E, Scott DL (1998) Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Comparative effects of different antigens. Scand J Rheumatol 27:46–53PubMedCrossRef Houssien DA, Jonsson T, Davies E, Scott DL (1998) Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis. Comparative effects of different antigens. Scand J Rheumatol 27:46–53PubMedCrossRef
12.
go back to reference Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677–680PubMedCrossRef Bas S, Genevay S, Meyer O, Gabay C (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 42:677–680PubMedCrossRef
13.
go back to reference Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430PubMedCrossRef Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62:427–430PubMedCrossRef
14.
go back to reference Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 46:65–71PubMed Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E, Monier JC (1987) IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis. Ann Rheum Dis 46:65–71PubMed
15.
go back to reference Eberhardt KB, Svensson B, Truedsson L, Wollheim FA (1988) The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis—no relationship with erosions or disease activity. J Rheumatol 15:1070–1074PubMed Eberhardt KB, Svensson B, Truedsson L, Wollheim FA (1988) The occurrence of rheumatoid factor isotypes in early definite rheumatoid arthritis—no relationship with erosions or disease activity. J Rheumatol 15:1070–1074PubMed
16.
go back to reference McDougal JS, Hubbard M, McDuffie FC, Strobel PL, Smith SJ, Bass N, Goldman JA, Hartman S, Myerson G, Miller S, Morales R, Wilson CH Jr (1982) Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity in rheumatoid arthritis. Arthritis Rheum 25:1156–1166PubMedCrossRef McDougal JS, Hubbard M, McDuffie FC, Strobel PL, Smith SJ, Bass N, Goldman JA, Hartman S, Myerson G, Miller S, Morales R, Wilson CH Jr (1982) Comparison of five assays for immune complexes in the rheumatic diseases. An assessment of their validity in rheumatoid arthritis. Arthritis Rheum 25:1156–1166PubMedCrossRef
17.
go back to reference Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685PubMed Withrington RH, Teitsson I, Valdimarsson H, Seifert MH (1984) Prospective study of early rheumatoid arthritis. II. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann Rheum Dis 43:679–685PubMed
18.
go back to reference Highton J, Hessian PA, Small B, Palmer DG (1985) An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 12:854–858PubMed Highton J, Hessian PA, Small B, Palmer DG (1985) An assessment of the diagnostic value of quantitative measurements of IgA rheumatoid factor. J Rheumatol 12:854–858PubMed
19.
go back to reference Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, Cats A, Lindeman J (1985) Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int 5:209–214PubMedCrossRef Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, Cats A, Lindeman J (1985) Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int 5:209–214PubMedCrossRef
20.
go back to reference March RE, Kirwan JR, Reeback JS, Holborow EJ (1987) IgM, IgG and IgA rheumatoid factors (antiglobulins) in early rheumatoid arthritis and their production of articular index over one year. Scand J Rheumatol 16:407–411PubMedCrossRef March RE, Kirwan JR, Reeback JS, Holborow EJ (1987) IgM, IgG and IgA rheumatoid factors (antiglobulins) in early rheumatoid arthritis and their production of articular index over one year. Scand J Rheumatol 16:407–411PubMedCrossRef
21.
go back to reference Carpenter AB, Smailer S (1989) Measurement of rheumatoid factor isotypes in the clinical laboratory. Immunol Invest 18:765–773PubMed Carpenter AB, Smailer S (1989) Measurement of rheumatoid factor isotypes in the clinical laboratory. Immunol Invest 18:765–773PubMed
22.
go back to reference Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J (1998) Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren’s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 16:709–715PubMed Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J (1998) Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren’s syndrome and rheumatoid arthritis. Clin Exp Rheumatol 16:709–715PubMed
23.
go back to reference Luthviksson BR, Jonsson T, Erlendsson K, Sigfusson A (1992) Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol 21:1–4PubMed Luthviksson BR, Jonsson T, Erlendsson K, Sigfusson A (1992) Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol 21:1–4PubMed
24.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
25.
go back to reference Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315PubMedCrossRef Pinals RS, Masi AT, Larsen RA (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24:1308–1315PubMedCrossRef
26.
go back to reference Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 8:481–491 Larsen A, Dale K, Eek M (1977) Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 8:481–491
27.
go back to reference Hochberg MC, Chang RW, Dwash I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502PubMed Hochberg MC, Chang RW, Dwash I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498–502PubMed
28.
go back to reference Jonsson T, Valdimarsson H (1992) Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 12:111–113PubMedCrossRef Jonsson T, Valdimarsson H (1992) Clinical significance of rheumatoid factor isotypes in seropositive arthritis. Rheumatol Int 12:111–113PubMedCrossRef
29.
go back to reference Jonsson T, Valdimarsson H (1993) Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 52:161–164PubMedCrossRef Jonsson T, Valdimarsson H (1993) Is measurement of rheumatoid factor isotypes clinically useful? Ann Rheum Dis 52:161–164PubMedCrossRef
Metadata
Title
Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study
Authors
Aşkin Ateş
Gülay Kinikli
Murat Turgay
Gülay Akay
Güner Tokgöz
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0343-x

Other articles of this Issue 4/2007

Clinical Rheumatology 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.